Last reviewed · How we verify
NCT07351084
Patient Factors Associated With Fragmentation of Copper Intrauterine Devices Requiring Hysteroscopic Removal
trial testing Hysteroscopy in Intrauterine Device Complications in 45 participants. Completed in 26 June 2025.
26 June 2025
Quick facts
| Lead sponsor | University of Kansas Medical Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 45 |
| Start date | 28 February 2025 |
| Primary completion | 26 June 2025 |
| Estimated completion | 26 June 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Hysteroscopy
Conditions studied
- Intrauterine Device Complications — all drugs for Intrauterine Device Complications →
- Contraceptive Device Failure — all drugs for Contraceptive Device Failure →
- IUD Fragmentation — all drugs for IUD Fragmentation →
- Retained Intrauterine Device — all drugs for Retained Intrauterine Device →
Sponsor
University of Kansas Medical Center
Who can join
Adults 18 to 60, female only, with Intrauterine Device Complications or Contraceptive Device Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this retrospective chart review was to identify risks factors for patients associated to Cooper IUD fragmentation upon removal resulting in the requirement of a hysteroscopy evaluation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07351084
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Hysteroscopy
Trials testing the same drug.
- NCT07309692 — Different Modalities for the Evaluation of Patients With Peri-menopausal Bleeding · NA · recruiting
- NCT07095647 — Surgical Management of Cesarean Scar Ectopic Pregnancy: Hysteroscopy & Laparoscopy Outcomes · NA · completed
- NCT05717634 — Endometrial Changes in Breast Cancer Women. · unknown
- NCT05412771 — Evolutive and Functional Bases of Menstruation in Women - 2 · NA · recruiting
- NCT04736095 — 3 Dimensional Ultrasound in Comparison to Hysteroscopy in Myomas · completed
Other University of Kansas Medical Center trials
Trials by the same sponsor.
- NCT06636214 — Adapting Changing Talk: Online (CHATO) to CHATO-Inclusive · NA · not yet recruiting
- NCT07528963 — KanSurvive 2.0: Testing Enhanced Models of Cancer Survivorship Care for Rural Cancer Survivors in Primary Care Practice · NA · enrolling by invitation
- NCT07463755 — Low-Fidelity Driving Simulator Training in Parkinson's Disease. · NA · not yet recruiting
- NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
- NCT07491510 — Improving Prenatal Care to Reduce Early Onset Preeclampsia in Low-Income · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07351084 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Kansas Medical Center
- Last refreshed: 20 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07351084.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing